Related Experiment Video
Updated: Jun 24, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin
Paul Antek Matthias Ecker1, Andreas Schaper2,3, Hans Jörg Bräunig2,3
1Institute of Pharmacology, Hannover Medical School, Hannover, D-30625, Germany.
Purpose & Background:
Belonging to one of the oldest drug classes in cardiovascular-medicine, the scientific interest in Na+/K+-ATPase inhibitors (NKA-inhibitors, digitalis glycosides) has increased once again after the publication of the recent DIGIT-HF study. This analysis and scoping review aim to assess long-term prescribing trends of NKA-inhibitors and poison center data to investigate the discrepancy between declining use and increasing poison center reports involving digitoxin in Germany.
Methods:
By using prescription data (defined daily dose, DDD) and poison center records between 1990 and 2023 in Germany we conducted a pharmacological, pharmacoeconomic and toxicological analysis of the four NKA-inhibitors digitoxin, digoxin, acetyldigoxin and metildigoxin. For identifying trend changes and prescribing trends, we used joinpoint regression and DDD-half-time analyses.
Results:
The DDD of NKA-inhibitors declined substantially over our investigated timeframe. Reported exposure cases involving digitoxin, recorded by the GIZ-Nord poison center, showed a significant and continuous increase. Population-adjusted exposure cases increased by 4.65% per year. Exposure-adjusted exposure cases per 1 mio. DDD increased by 11.80% per year. The data for reported cases involving digoxin showed large year-to-year variability and no significant increase in reported case numbers. The PRISM DDD-half-time analysis showed big differences between the four substances, with digitoxin exhibiting the longest DDD-half-time despite the absence of supportive evidence in the form of clinical trials, suggesting a dissociation between evidence and real-world prescriptions.
Conclusions:
Prescription volumes decrease but digitoxin is associated with steadily increasing reports of exposure cases from poison center data. This indicates discrepancies between prescribing trends and real-world exposure patterns and highlights the importance for patient selection and careful monitoring, especially in elderly patients.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Pharmaceutical Poisoning: Potential Scenarios
Drug Toxicity: Dose-Dependent Reactions
Toxidromes: Clinical Features
Drug Toxicity: Overview
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...